San Carlos, California, United States | Fund Name | Location |
| Aciturri | Castilla y Leon, Miranda De Ebro, Spain |
| American Public Media | Minnesota, Saint Paul, United States |
| AngelFire Ventures | Mineola, New York, United States |
| Apricot Capital | Boston, Massachusetts, United States |
| Bahrain Mumtalakat Holding | Bahrain, Capital Governorate, Manama |
| Bear Stearns | Atlanta, Georgia, United States |
| Chuxin Capital | Beijing, Beijing, China |
| Cretrend Capital | Beijing, Beijing, China |
| Flywheel Ventures | New Mexico, Santa Fe, United States |
| Hennessey Capital | Michigan, Rochester Hills, United States |
| Kaiheng Investment Management | - |
| La French Tech | France, Ile-de-France, Paris |
| Linkmore Capital | - |
| NextLevel Management | Florida, New York, United States |
| Peninsula Business Services | England, Manchester, United Kingdom |
| Potential VC | England, London, United Kingdom |
| Praxis Capital Partners | - |
| Rabo Ventures | Amsterdam, Noord-Holland, The Netherlands |
| Spring Camp | Seoul, Seoul-t'ukpyolsi, South Korea |
| Vestia | Fort Wayne, Indiana, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Pearl Therapeutics | $18M | 03 Jul 2008 | Morristown, New Jersey, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Pearl Therapeutics | $18M | 03 Jul 2008 | Morristown, New Jersey, United States |
